Other examples of potential functional interactions might include the receptor for long-chain saturated fatty acids, FFA1, which is also expressed in pancreatic beta cells, where its activation leads to GSIS potentiation via G q transducer pathways (Kimura et al., 2020), as well as in hepatocytes (Secor et al., 2021) and enteroendocrine L and K cells, where it contributes to incretin hormone secretion, with FFA1 KO mice exhibiting obesity on a low-fat diet (Lu et al., 2021)
Similarly, TZDs are as effective as GLP-1RAs in HbA 1C reduction, have fewer GI effects and may have a lower hypoglycaemia risk, but can cause weight gain
This frustrating shift has led many perimenopausal women to explore GLP-1 weight loss medications as a potential solution for hormonal weight gain
5-on, 2-off weekly: Five days of injections followed by two days off each week
The decision, buried within the Department of Health Care Services (DHCS) cost-saving adjustments, comes after a year in which these drugs accounted for more than $1.6 billion in Medicaid reimbursements statewide